Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to reduce reperfusion injury after coronary revascularization in acute myocardial infarct
It seems clear that we should take advantage of the microgravity of the International Space Station (ISS) to serve as a laboratory in the investigation of a